Skip to content
Steady
Get Steady
ScienceJune 11, 20263 min read

The newest GLP-1 worry is about your bones. Here is the calm, accurate version.

New research links GLP-1 use to a modest rise in osteoporosis: roughly 4% of users versus 3% of non-users. The likely cause is not the drug itself but the rapid weight and muscle loss that comes with it, which is preventable.

What happened

A wave of 2026 research has put a new item on the GLP-1 worry list: bone health. One large analysis of people with obesity and type 2 diabetes found that GLP-1 users were somewhat more likely to develop osteoporosis, roughly 4% of users versus about 3% of non-users, a modest but real difference.

That sounds frightening next to a weight-loss drug. But the explanation, and the fix, are more reassuring than the headline.

Why this happens (and why it is not really about the drug)

Researchers do not think the medication is attacking your bones directly. They think the cause is the weight loss itself, and especially the kind of weight loss.

Two things drive it. First, your bones are living tissue that stays strong partly by being loaded, by carrying weight and being worked. Lose weight quickly and you reduce that load, and bone can thin in response. Second, as we have written before, a meaningful share of fast weight loss is muscle, and muscle is one of the main things that pulls on and protects bone. Lose muscle, and bone loses an ally.

In other words, this is the same underlying story as the muscle question, seen from the skeleton's side. Rapid loss without protection costs you lean tissue, and bone is part of the bill.

It is also genuinely mixed evidence: some 2026 studies found GLP-1 users with existing bone disorders actually had lower fracture risk, probably because they were moving more and carrying less strain on their joints. The picture is not settled. The sensible response is not fear; it is protection.

Why it is sharper for women

Women start with less bone than men and lose it faster after menopause, when falling oestrogen strips away about 1% of bone density a year on its own. A GLP-1's rapid weight loss on top of that is, again, a second subtraction at exactly the wrong time. This is not a reason to avoid these drugs. It is a reason to protect bone deliberately while you use them.

What it means for you

The protection for your bones is, happily, almost identical to the protection for your muscle:

  • Resistance training. Loading your muscles loads your bones. Two short sessions a week is the single best thing you can do for both. (See strength training that fits a tired body.)
  • Enough protein. Bone is not just calcium; its framework is protein. The same ~120g a day that protects muscle supports bone too.
  • The basics your doctor will mention: adequate calcium and vitamin D, and a conversation about a bone-density (DEXA) scan if you are postmenopausal or losing weight fast.

What Steady does with this

The thread running through every one of these GLP-1 worries, muscle, movement, now bone, is the same: protect your lean, loaded tissue while you lose, and most of the risk falls away. That is the single idea Steady is built around.

  • Steady tracks your strength sessions in a weekly scorecard, the one habit that protects muscle and bone at once.
  • It holds your protein target on the home screen, the raw material both are built from.
  • It turns your month into one clear page for your prescriber, so a conversation about a DEXA scan or your bone health is grounded in what you have actually been doing.

The scale cannot see your bones. Steady is built around everything the scale cannot see.

Read the originalNBC News / Nature Bone ResearchOpen
Go deeper

The news changes weekly. What protects your body doesn't.

Steady is the daily companion for women on a GLP-1: protein, muscle, symptoms and cycle, in one place. Free on the App Store.

Free to start. Subscription unlocks the full app. iPhone only.

More from the Brief